Barone, F., Tak, P. P., Bloomston, M., Webber, E., Dwyer, J., Nichols, W. G., . . . Swan, R. (2023). 653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC). BMJ Publishing Group.
Chicago Style (17th ed.) CitationBarone, Francesca, et al. 653 Neoadjuvant CAN-2409+Prodrug Plus Chemoradiation for Borderline Resectable or Locally Advanced Non-metastatic Pancreatic Adenocarcinoma (PDAC). BMJ Publishing Group, 2023.
MLA (9th ed.) CitationBarone, Francesca, et al. 653 Neoadjuvant CAN-2409+Prodrug Plus Chemoradiation for Borderline Resectable or Locally Advanced Non-metastatic Pancreatic Adenocarcinoma (PDAC). BMJ Publishing Group, 2023.
Warning: These citations may not always be 100% accurate.